Evidence map›Paper›PMID 20830296›Full record

ArticlePloS one2010

Long-term IGF-I exposure decreases autophagy and cell viability.

Alessandro Bitto, Chad Lerner, Claudio Torres, Michaela Roell, Marco Malaguti, Viviana Perez, Antonello Lorenzini, Silvana Hrelia, Yuji Ikeno, Michelle Elizabeth Matzko and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. The IGF System and Aging.Endocrine reviews · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Sensory Neuromodulation.Frontiers in systems neuroscience · 2020
    Article
  17. Article
  18. Article
  19. Enhancing Autophagy Diminishes Aberrant CaFrontiers in physiology · 2019
    Article
  20. Obesity May Accelerate the Aging Process.Frontiers in endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Alessandro BittoDepartment of Pathology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Chad Lerner
Claudio Torres
Michaela Roell
Marco Malaguti
Viviana Perez
Antonello Lorenzini
Silvana Hrelia
Yuji Ikeno
Michelle Elizabeth Matzko
Roger McCarter
Christian Sell
Drexel University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Bologna · ITAudie L. Murphy Memorial VA Hospital · USPennsylvania State University · US

Funding

Role of IGF-1 in Modulation of LongevityR01AG022443 · NIA · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI SELL, CHRISTIAN · 2005 to 2009
$1.7M
NIA NIH HHS AG022443NIA NIH HHS R01 AG022443
6 · The paper itself

Abstract

A reduction in IGF-I signaling has been found to increase lifespan in multiple organisms despite the fact that IGF-I is a trophic factor for many cell types and has been found to have protective effects against multiple forms of damage in acute settings. The increase in longevity seen in response to reduced IGF-I signaling suggests that there may be differences between the acute and chronic impact of IGF-I signaling. We have examined the possibility that long-term stimulation with IGF-I may have a negative impact at the cellular level using quiescent human fibroblasts. We find that fibroblast cells exposed to IGF-I for 14 days have reduced long-term viability as judged by colony forming assays, which is accompanied by an accumulation of senescent cells. In addition we observe an accumulation of cells with depolarized mitochondria and a reduction in autophagy in the long-term IGF-I treated cultures. An examination of mice with reduced IGF-I levels reveals evidence of enhanced autophagy and fibroblast cells derived from these mice have a larger mitochondrial mass relative to controls indicating that changes in mitochondrial turnover occurs in animals with reduced IGF-I. The results indicate that chronic IGF-I stimulation leads to mitochondrial dysfunction and reduced cell viability.

Indexed as

AutophagyAnimalsApoptosisCells, CulturedCell SurvivalFibroblastsInsulin-Like Growth Factor IMiceMitochondriaInsulin-Like Growth Factor I

Identifiers

PMID20830296
PMCPMC2935370
OpenAlexW2026696924

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.